Trifluoromescaline
Trifluoromescaline (TF-M) is a derivative of the phenethylamine hallucinogen mescaline, which has a trifluoromethoxy group replacing the central methoxy group of mescaline. Synthesis of this compound was first reported by Daniel Trachsel in 2011, alongside many other related compounds.[1][2] Trifluoromescaline was found to be one of the most potent compounds in the series, with a reported dosage of 15-40mg (and 60mg being described as a "strong overdose"), and a slow onset of action and long duration of effects, lasting 14-24 hours or more.[3]
![]() | |
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
Chemical and physical data | |
Formula | C11H14F3NO3 |
Molar mass | 265.228 g/mol g·mol−1 |
3D model (JSmol) | |
SMILES
| |
InChI
|
See also
- 2C-TFM
- 3C-DFE
- 4-TM
- Allylescaline
- 2-Bromomescaline
References
- Trachsel D. Synthese von neuen (Phenylalkyl)aminen zur Untersuchung von Struktur-Aktivitätsbeziehungen, Mitteilung 1, Mescalin Derivate. Helvetica Chimica Acta. 2002; 85(9):3019–3026. doi:10.1002/1522-2675(200209)85:9<3019::AID-HLCA3019>3.0.CO;2-4
- Trachsel D. Fluorine in psychedelic phenethylamines. Drug Testing and Analysis. Dec 2011. doi:10.1002/dta.413
- Daniel Trachsel, David Lehmann and Christoph Enzensperger. Phenethylamine Von der Struktur zur Funktion, pp 704-723. Nachtschatten Verlag AG, 2013. ISBN 978-3-03788-700-4
Phenethylamines |
|
---|---|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
Psychedelics (5-HT2A agonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dissociatives (NMDAR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deliriants (mAChR antagonists) |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Others |
|
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.